SCHEMBL3784708

SCHEMBL3784708

COc1cc(-c2cccc(N)c2)ccc1N

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.74
CYP3A4 P08684 3/20 0.74
HSD17B10 Q99714 2/20 0.74
TDP1 Q9NUW8 2/20 0.74
TSHR P16473 1/20 0.74
MAOA P21397 1/20 0.50
APP P05067 1/20 0.50
CHEK1 O14757 3/20 0.48
FYN P06241 1/20 0.48
MAPT P10636 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
HPGD P15428 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KIT P10721 2/20 0.47
NTRK1 P04629 1/20 0.47
ADRA2B P18089 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL980277 0.87 NTRK1 (0.58) ALDH1A1CYP3A4HSD17B10TDP1TSHR
SCHEMBL29399235 0.86 ALDH1A1 (1.00) ALDH1A1CYP3A4HSD17B10TDP1TSHR
SCHEMBL48945 0.86 ALDH1A1 (1.00) ALDH1A1CYP3A4HSD17B10TDP1TSHR
SCHEMBL3783522 0.85 ALDH1A1 (0.52) ALDH1A1CYP3A4HSD17B10TDP1TSHR
SCHEMBL358211 0.85 ALDH1A1 (0.80) ALDH1A1CYP3A4HSD17B10TDP1TSHR
Ammonia Solution, Strong SCHEMBL2259240 0.84 ALDH1A1 (0.95) ALDH1A1CYP3A4HSD17B10TDP1TSHR
Methane SCHEMBL28975440 0.84 ALDH1A1 (0.95) ALDH1A1CYP3A4HSD17B10TDP1TSHR
Hydrochloric Acid SCHEMBL29494721 0.84 ALDH1A1 (0.95) ALDH1A1CYP3A4HSD17B10TDP1TSHR
Hydrochloric Acid SCHEMBL622811 0.84 ALDH1A1 (0.95) ALDH1A1CYP3A4HSD17B10TDP1TSHR
Hydrochloric Acid SCHEMBL30913021 0.84 ALDH1A1 (0.95) ALDH1A1CYP3A4HSD17B10TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 ALDH1A1 4339/4885CYP3A4 177/4885HSD17B10 1100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.